A comparative study of docetaxel and B.C.G interavesical with B.C.G alone for prophylaxis of post TUR bladder cancer recurrence.
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Docetaxel (Primary) ; BCG
- Indications Bladder cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2011 New trial record